首页> 外文期刊>American Journal of Physiology >QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder
【24h】

QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder

机译:抑郁和恐慌症患者的QT间期变异性和心脏去甲肾上腺素溢出

获取原文
获取原文并翻译 | 示例
           

摘要

First published July 3,2008; doi: 10.1152/ajpheart.00301.2008.-Suggestions were made that increased myocardial sympathetic activity is reflected by elevated QT variability (dynamic changes in QT interval duration). However, the relationship between QT variability and the amount of norepinephrine released from the cardiac sympathetic terminals is unknown. We thus attempted to assess this relationship. The study was performed in 17 subjects (12 with major depressive disorder and 5 with panic disorder). Cardiac norepinephrine spillover (measured by direct catheter technique coupled with norepinephrine isotope dilution methodology) was assessed before and 4 mo after treatment with selective serotonin reuptake inhibitor (SSRI) antidepressants. The distribution of the cardiac norepinephrine spillover was bimodal, with the majority of patients having values of s<=10 10 ng/min. There was a positive correlation between cardiac norepinephrine spillover and corrected QT interval (r = 0.7, P = 0.03) but not with any of the QT variability measures. However, in a subgroup of five patients who had high levels of cardiac norepinephrine spillover (>20 ng/min) a tendency for a strong positive correlation with variance of QT intervals (r = 0.9, P = 0.08) was observed. There were significant correlations between the severity of depression and QT variability indexes normalized to the heart rate [QTVi and QT interval/R-R interval (QT/RR) coherence] and between the severity of anxiety and the QT/RR residual and regression coefficient, respectively. Treatment with SSRI antidepressants substantially reduced depression score but did not affect any of the QT variability indexes. We conclude that in depression/panic disorder patients with near-normal cardiac norepinephrine levels QT variability is not correlated with cardiac norepinephrine spillover and is not affected by treatment with SSRI.
机译:2008年7月3日首次发布; doi:10.1152 / ajpheart.00301.2008.-有人提出,增加的QT变异性(QT间隔持续时间的动态变化)反映了心肌交感神经活动的增强。但是,QT变异性与从心脏交感神经末梢释放的去甲肾上腺素的量之间的关系尚不清楚。因此,我们试图评估这种关系。该研究在17位受试者中进行(其中12位患有重度抑郁症,而5位患有惊恐症)。在使用选择性5-羟色胺再摄取抑制剂(SSRI)抗抑郁药治疗之前和之后4个月,评估了心脏的去甲肾上腺素溢出(通过直接导管技术结合去甲肾上腺素同位素稀释方法测量)。心脏去甲肾上腺素溢出的分布是双峰的,大多数患者的s <= 10 10 ng / min。心脏去甲肾上腺素溢出与校正后的QT间期之间呈正相关(r = 0.7,P = 0.03),但与任何QT变异性测量均不相关。但是,在五个人的心脏去甲肾上腺素外溢水平较高(> 20 ng / min)的亚组中,观察到与QT间期变化呈强正相关的趋势(r = 0.9,P = 0.08)。抑郁症的严重程度与根据心率归一化的QT变异性指标[QTVi和QT间隔/ RR间隔(QT / RR)相干性]之间以及焦虑的严重程度与QT / RR残差和回归系数之间存在显着相关性。用SSRI抗抑郁药治疗可显着降低抑郁评分,但不影响任何QT变异性指标。我们得出的结论是,在患有接近正常的心脏去甲肾上腺素水平的抑郁症/恐慌症患者中,QT变异性与心脏去甲肾上腺素外溢无关,并且不受SSRI治疗的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号